Chlorhexidine is a highly effective topical broad-spectrum agent against Candida spp.

International Journal of Antimicrobial Agents

Volumn 41, Issue 1, 2013, Pages 65-69

  Salim, N ^a,b   Moore, C ^a,c   Silikas, N ^a   Satterthwaite, J ^a   Rautemaa, R ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF JORDAN   (Jordan)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Candida; Chlorhexidine; Fluconazole; Minimum inhibitory concentration; Susceptibility

Indexed keywords

CHLORHEXIDINE; FLUCONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS ISOLATION; GROWTH INHIBITION; IN VITRO STUDY; KLUYVEROMYCES MARXIANUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; REPRODUCIBILITY; SALIVA LEVEL;

ANTI-INFECTIVE AGENTS, LOCAL; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; CHLORHEXIDINE; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84871650604     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.08.014     Document Type: Article

References (31)

1. B.J. Coco, J. Bagg, L.J. Cross, A. Jose, J. Cross, and G. Ramage Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis Oral Microbiol Immunol 23 2008 377 383
2. R. Rautemaa, and G. Ramage Oral candidosis - clinical challenges of a biofilm disease Crit Rev Microbiol 37 2011 328 336
3. G. Ramage, S.P. Saville, D.P. Thomas, and J.L. Lopez-Ribot Candida biofilms: an update Eukaryot Cell 4 2005 633 638
4. L.E. Cowen, J.B. Anderson, and L.M. Kohn Evolution of drug resistance in Candida albicans Annu Rev Microbiol 56 2002 139 165
5. L.P. Samaranayake, W. Keung Leung, and L. Jin Oral mucosal fungal infections Periodontol 2000 49 2009 39 59
6. E. Siikala, R. Rautemaa, M. Richardson, H. Saxen, P. Bowyer, and D. Sanglard Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients J Antimicrob Chemother 65 2010 2505 2513
7. M. Richardson, and D. Warnock Fungal infection: diagnosis and management 4th ed. 2012 Wiley-Blackwell Chichester, UK
8. J. Bagg, M.P. Sweeney, M.A.O. Lewis, M.S. Jackson, D. Coleman, and A.A. Mosaid High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer Palliat Med 17 2003 477 481
9. G. Ramage, S. Bachmann, T.F. Patterson, B.L. Wickes, and J.L. Lopez-Ribot Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms J Antimicrob Chemother 49 2002 973 980
10. J. Blomgren, U. Beiggren, and M. Jontell Fluconazole versus nystatin in the treatment of oral candidosis Acta Odontol Scand 56 1998 202 205
11. C.W. Su, S. Gaskie, B. Jamieson, and D. Triezenberg What is the best treatment for oral thrush in healthy infants? J Fam Pract 57 2008 484 485
12. G. Ramage, K. VandeWalle, S.P. Bachmann, B.L. Wickes, and J.L. Lopez-Ribot In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies Antimicrob Agents Chemother 46 2002 3634 3636
13. G. Ramage, A. Jose, B. Coco, R. Rajendran, R. Rautemaa, and C. Murray Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 456 460
14. A.N. Ellepola, and L.P. Samaranayake Adjunctive use of chlorhexidine in oral candidoses: a review Oral Dis 7 2001 11 17
15. I. Tomas, M.C. Cousido, L. Gracia-Caballero, S. Rubido, J. Limeres, and P. Diz Substantivity of a single chlorhexidine mouthwash on salivary flora: influence of intrinsic and extrinsic factors J Dent 38 2010 541 546
16. A.N. Ellepola, and L.P. Samaranayake The effect of brief exposure to sub-therapeutic concentrations of chlorhexidine gluconate on the germ tube formation of oral Candida albicans and its relationship to post-antifungal effect Oral Dis 6 2000 166 171
17. S.J. Hiom, J.R. Furr, A.D. Russell, and J.R. Dickinson Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae J Appl Bacteriol 72 1992 335 340
18. J.M. Thurmond, A.T. Brown, R.E. Sims, G.A. Ferretti, T.P. Raybould, and T.T. Lillich Oral Candida albicans in bone marrow transplant patients given chlorhexidine rinses: occurrence and susceptibilities to the agent Oral Surg Oral Med Oral Pathol 72 1991 291 295
19. A.M.G. Darwazeh, P.J. Lamey, T.W. MacFarlane, and A.C. McCuish The effect of exposure to chlorhexidine gluconate in vitro and in vivo on in vitro adhesion of Candida albicans to buccal epithelial cells from diabetic and non-diabetic subjects J Oral Pathol Med 23 1994 130 132
20. E.A. O'Sullivan, M.S. Duggal, C.C. Bailey, M.E.J. Curzon, and P. Hart Changes in the oral microflora during cytotoxic chemotherapy in children being treated for acute leukemia Oral Surg Oral Med Oral Pathol 76 1993 161 168
21. D.M. Kuhn, T. George, J. Chandra, P.K. Mukherjee, and M.A. Ghannoum Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins Antimicrob Agents Chemother 46 2002 1773 1780
22. N. Salim, C. Moore, N. Silikas, J.D. Satterthwaite, and R. Rautemaa Fungicidal amounts of antifungals are released from impregnated denture lining material for up to 28 days J Dent 40 2012 506 512
23. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; third informational supplement. Document M27-S3. Wayne, PA: CLSI; 2008.
24. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 3rd ed. Document M27-A3. Wayne, PA: CLSI; 2008.
25. J. Versalovic Manual of clinical microbiology 10th ed. 2011 ASM Press Washington, DC
26. P. Bonesvoll, and P. Gjermo A comparison between chlorhexidine and some quaternary ammonium compounds with regard to retention, salivary concentration and plaque-inhibiting effect in the human mouth after mouth rinses Arch Oral Biol 23 1978 289 294
27. R.W. Force, and M.C. Nahata Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis Ann Pharmacother 29 1995 10 15
28. G. Giuliana, G. Pizzo, M.E. Milici, and R. Giangreco In vitro activities of antimicrobial agents against Candida species Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87 1999 44 49
29. J. Slots, T.E. Rams, and S.E. Schonfeld In vitro activity of chlorhexidine against enteric rods, pseudomonads and Acinetobacter from human periodontitis Oral Microbiol Immunol 6 1991 62 64
30. K. Lal, R.P. Santarpia, J.J. Pollock, and R.P. Renner Assessment of antimicrobial treatment of denture stomatitis using an in vivo replica model system: therapeutic efficacy of an oral rinse J Prosthet Dent 67 1992 72 77
31. M.A. Pfaller, D. Andes, D.J. Diekema, A. Espinel-Ingroff, and D. Sheehan Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods Drug Resist Updat 13 2010 180 195